{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T14:17:54Z","timestamp":1784557074513,"version":"3.55.0"},"reference-count":12,"publisher":"Bioscientifica","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["edm.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,1,1]]},"abstract":"<jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can impair pituitary\u2013gonadal axis and a higher prevalence of hypogonadism in post-coronavirus disease 2019 (COVID-19) patients compared with the general population has been highlighted. Here we report the first case of a patient affected with a long-COVID syndrome leading to hypogonadism and treated with testosterone replacement therapy (TRT) and its effects on clinical and quality of life (QoL) outcomes. We encountered a 62-year-old man who had been diagnosed with hypogonadotropic hypogonadism about 2 months after recovery from COVID-19 underwent a complete physical examination, general and hormonal blood tests, and self-reported questionnaires administration before and after starting TRT. Following the TRT, both serum testosterone level and hypogonadism-related symptoms were improved, but poor effects occurred on general and neuropsychiatric symptoms and QoL. Therefore, hypogonadism does not appear to be the cause of neurocognitive symptoms, but rather a part of the long-COVID syndrome; as a consequence, starting TRT can improve the hypogonadism-related symptoms without clear benefits on general clinical condition and QoL, which are probably related to the long-COVID itself. Longer follow-up might clarify whether post-COVID hypogonadism is a transient condition that can revert as the patient recovers from long-COVID syndrome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Learning points<\/jats:title>\n                    <jats:list list-type=\"bullet\">\n                      <jats:list-item>\n                        <jats:p>Hypogonadism is more prevalent in post-COVID-19 patients compared with the general population.<\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>In these patients, hypogonadism may be part of long-COVID syndrome, and it is still unclear whether it is a transient condition or a permanent impairment of gonadal function.<\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>Testosterone replacement therapy has positive effects on hypogonadism-related clinic without clear benefits on general symptomatology and quality of life, which are more likely related to the long-COVID itself.<\/jats:p>\n                      <\/jats:list-item>\n                    <\/jats:list>\n                  <\/jats:sec>","DOI":"10.1530\/edm-23-0097","type":"journal-article","created":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T08:09:29Z","timestamp":1711094969000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-2","source":"Crossref","is-referenced-by-count":4,"title":["Use of testosterone replacement therapy to treat long-COVID-related hypogonadism"],"prefix":"10.1530","volume":"2024","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-0224-8104","authenticated-orcid":true,"given":"Alessandro","family":"Amodeo","sequence":"first","affiliation":[{"name":"Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2068-9581","authenticated-orcid":true,"given":"Luca","family":"Persani","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy"},{"name":"Department of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5454-6074","authenticated-orcid":true,"given":"Marco","family":"Bonomi","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy"},{"name":"Department of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biagio","family":"Cangiano","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy"},{"name":"Department of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"bib1","series-title":"Lancet. Infectious Diseases","first-page":"e102","article-title":"A clinical case definition of post-COVID-19 condition by a Delphi consensus","volume":"22","author":"Soriano","year":"2022","unstructured":"Soriano JBMurthy SMarshall JCRelan PDiaz JV & WHO Clinical Case Definition Working Group on Post-COVID-19 Condition. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet. Infectious Diseases202222e102\u2013e107. (https:\/\/doi.org\/10.1016\/S1473-3099(2100703-9)"},{"key":"bib2","series-title":"Journal of Clinical Medicine","article-title":"Detection of male hypogonadism in patients with post COVID-19 condition","volume":"11","author":"Yamamoto","year":"2022","unstructured":"Yamamoto YOtsuka YSunada NTokumasu KNakano YHonda HSakurada YHagiya HHanayama Y & Otsuka F. Detection of male hypogonadism in patients with post COVID-19 condition. Journal of Clinical Medicine202211. (https:\/\/doi.org\/10.3390\/jcm11071955)"},{"key":"bib3","series-title":"Journal of Endocrinological Investigation","first-page":"2207","article-title":"Andrological effects of SARS-Cov-2 infection: a systematic review and meta-analysis","volume":"45","author":"Corona","year":"2022","unstructured":"Corona GVena WPizzocaro APallotti FPaoli DRastrelli GBaldi ECilloni NGacci MSemeraro F, et al.Andrological effects of SARS-Cov-2 infection: a systematic review and meta-analysis. Journal of Endocrinological Investigation2022452207\u20132219. (https:\/\/doi.org\/10.1007\/s40618-022-01801-x)"},{"key":"bib4","series-title":"Clinical Endocrinology","first-page":"353","article-title":"Male pituitary-gonadal axis dysfunction in post-acute COVID-19 syndrome-Prevalence and associated factors: a Mediterranean case series","volume":"96","author":"Moreno-Perez","year":"2022","unstructured":"Moreno-Perez OMerino EAlfayate RTorregrosa MEAndres MLeon-Ramirez JMBoix VGil JPico A & COVID19-ALC ResearchGroup. Male pituitary-gonadal axis dysfunction in post-acute COVID-19 syndrome-Prevalence and associated factors: a Mediterranean case series. Clinical Endocrinology202296353\u2013362. (https:\/\/doi.org\/10.1111\/cen.14537)"},{"key":"bib5","series-title":"JAMA Network Open","first-page":"e2229747","article-title":"Association of male hypogonadism with risk of hospitalization for COVID-19","volume":"5","author":"Dhindsa","year":"2022","unstructured":"Dhindsa SChampion CDeol ELui MCampbell RNewman JYeggalam ANadella SAhir VShrestha E, et al.Association of male hypogonadism with risk of hospitalization for COVID-19. JAMA Network Open20225e2229747. (https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.29747)"},{"key":"bib6","series-title":"Andrology","first-page":"34","article-title":"Testosterone in males with COVID-19: a 7-month cohort study","volume":"10","author":"Salonia","year":"2022","unstructured":"Salonia APontillo MCapogrosso PGregori SCarenzi CFerrara AMRowe IBoeri LLarcher ARamirez GA, et al.Testosterone in males with COVID-19: a 7-month cohort study. Andrology20221034\u201341. (https:\/\/doi.org\/10.1111\/andr.13097)"},{"key":"bib7","series-title":"Sexual Medicine Reviews","first-page":"271","article-title":"The sexual long COVID (SLC): erectile dysfunction as a biomarker of systemic complications for COVID-19 long haulers","volume":"10","author":"Sansone","year":"2022","unstructured":"Sansone AMollaioli DLimoncin ECiocca GB\u1eafc NHCao TNHou GYuan JZitzmann MGiraldi A, et al.The sexual long COVID (SLC): erectile dysfunction as a biomarker of systemic complications for COVID-19 long haulers. Sexual Medicine Reviews202210271\u2013285. (https:\/\/doi.org\/10.1016\/j.sxmr.2021.11.001)"},{"key":"bib8","series-title":"Human Reproduction Update","first-page":"177","article-title":"SARS-CoV-2, fertility and assisted reproduction","volume":"29","author":"Ata","year":"2023","unstructured":"Ata BVermeulen NMocanu EGianaroli LLundin KRautakallio-Hokkanen STapanainen JS & Veiga A. SARS-CoV-2, fertility and assisted reproduction. Human Reproduction Update202329177\u2013196. (https:\/\/doi.org\/10.1093\/humupd\/dmac037)"},{"key":"bib9","series-title":"Journal of Sexual Medicine","first-page":"256","article-title":"SARS-CoV-2 pneumonia affects male reproductive hormone levels: a prospective, cohort study","volume":"18","author":"Kadihasanoglu","year":"2021","unstructured":"Kadihasanoglu MAktas SYardimci EAral H & Kadioglu A. SARS-CoV-2 pneumonia affects male reproductive hormone levels: a prospective, cohort study. Journal of Sexual Medicine202118256\u2013264. (https:\/\/doi.org\/10.1016\/j.jsxm.2020.11.007)"},{"key":"bib10","series-title":"Turkish Journal of Medical Sciences","first-page":"620","article-title":"COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs","volume":"50","author":"Tufan","year":"2020","unstructured":"Tufan AAvano\u011flu G\u00fcler A & Matucci-Cerinic M. COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs. Turkish Journal of Medical Sciences202050620\u2013632. (https:\/\/doi.org\/10.3906\/sag-2004-168)"},{"key":"bib11","series-title":"Domestic Animal Endocrinology","first-page":"321","article-title":"The anti-gonadotropic effects of cytokines: the role of neuropeptides","volume":"15","author":"Kalra","year":"1998","unstructured":"Kalra PSEdwards TGXu BJain M & Kalra SP. The anti-gonadotropic effects of cytokines: the role of neuropeptides. Domestic Animal Endocrinology199815321\u2013332. (https:\/\/doi.org\/10.1016\/s0739-7240(9800030-7)"},{"key":"bib12","series-title":"Molecular and Cellular Endocrinology","first-page":"107","article-title":"Metabolic syndrome induces inflammation and impairs gonadotropin-releasing hormone neurons in the preoptic area of the hypothalamus in rabbits","volume":"382","author":"Morelli","year":"2014","unstructured":"Morelli ASarchielli EComeglio PFilippi SVignozzi LMarini MRastrelli GManeschi ECellai IPersani L, et al.Metabolic syndrome induces inflammation and impairs gonadotropin-releasing hormone neurons in the preoptic area of the hypothalamus in rabbits. Molecular and Cellular Endocrinology2014382107\u2013119. (https:\/\/doi.org\/10.1016\/j.mce.2013.09.017)"}],"container-title":["Endocrinology, Diabetes &amp; Metabolism Case Reports"],"original-title":[],"link":[{"URL":"https:\/\/edm.bioscientifica.com\/view\/journals\/edm\/2024\/1\/EDM23-0097.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/edm.bioscientifica.com\/downloadpdf\/journals\/edm\/2024\/1\/EDM23-0097.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/edm.bioscientifica.com\/downloadpdf\/journals\/edm\/2024\/1\/EDM23-0097.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:48:18Z","timestamp":1784555298000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.bioscientifica.com\/edm\/article\/3652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,1]]},"references-count":12,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.1530\/edm-23-0097","relation":{},"ISSN":["2052-0573"],"issn-type":[{"value":"2052-0573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,1]]}}}